Brief: Lumos Diagnostics Says Entered Binding Convertible Note Agreements
20/11/2022 23:49
Nov 21 (Reuters) - Lumos Diagnostics LDX.AX :
* HAS ENTERED INTO BINDING CONVERTIBLE NOTE AGREEMENTS TO
RAISE UP
TO A$8.0M FROM US-BASED INSTITUTIONS
* FUNDS WILL SUPPORT COMPANY'S OPERATIONAL REQUIREMENTS INTO
FIRST
HALF OF FY24
Source text for Eikon: ID:nASX1QhgnW
Further company coverage: LDX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lumos Diagnostics Holdings
See all newsBrief: Lumos Diagnostics Posts FY26 Revenue Of $13.2 Million
Australia's Lumos Diagnostics soars on bagging purchase order for diagnostic test
Brief: Lumos Diagnostics Receives $767,800 Febridx Order From Phase Scientific
Brief: Lumos Diagnostics Signs Exclusive Distribution Agreement For Febridx In Romania
Brief: Lumos Diagnostics Posts FY26 Revenue Rises 6% To $13.2 Million